We found that miR-103a-3p had lower expression in DVT patients in comparison with the healthy volunteers, and the apoptosis and the level of TF in HUVECs were promoted by adding miR-103a-3p inhibitor under IL-1β treatment. Here, TF is linked to deep vein thrombosis.